Interventional Glaucoma: iStent Infinite and iDose

Show Description +

In this video, a patient with moderate primary open-angle glaucoma was taking three medications. I. Paul Singh, MD, shares his approach to be minimally invasive, spare as much trabecular meshwork as possible, and reduce the patient's drop burden.

Financial Disclosure: Consultant (Glaukos)

Posted: 1/31/2025

Interventional Glaucoma: iStent Infinite and iDose

In this video, a patient with moderate primary open-angle glaucoma was taking three medications. I. Paul Singh, MD, shares his approach to be minimally invasive, spare as much trabecular meshwork as possible, and reduce the patient's drop burden.

Financial Disclosure: Consultant (Glaukos)

Posted: 1/31/2025

Please log in to leave a comment.

More in Glaucoma

Angle-Based MIGS for a Patient With Severe Glaucoma

John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO

When a Minimally Invasive Procedure Fails

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Rachel G. Simpson, MD

Innovations in Glaucoma: The FYSX OPAP Device

I. Paul Singh, MD; and John P. Berdahl, MD

Challenging Cases: From PRK to IOP

Radhika Rampat, MBBS, BSc(Hons), FRCOphth, and Marguerite B. McDonald, MD, FACS